The world's smallest pacemaker was successfully implanted in a 92-year-old man at Medanta Medicity Hospital here, one of the first hospitals in the country to offer such a heart device, said a doctor on Thursday.
A senior doctor at Medanta said the world's smallest pacemaker was for patients with bradycardia, a condition characterised by a slow or irregular heart rhythm, usually fewer than 60 beats per minute.
Recently approved by the US Food and Drug Administration (FDA), the Micra Transcatheter Pacing System (TPS) is a new type of heart device that provides patients with the most advanced pacing technology at one-tenth the size of a traditional pacemaker.
The first procedure was performed by Balbir Singh, Chairman of Cardiac Electrophysiology and Pacing Section and also a Senior Interventional Cardiologist at Medanta Medicity Hospital here in Sector 38.
In patients suffering from bradycardia, the heart is unable to pump enough oxygen-rich blood to the body during normal activity or exercise, causing dizziness, fatigue, shortness of breath or fainting spells.
Pacemakers are the most common way to treat bradycardia.
Comparing it to the size of a large vitamin capsule, Singh selected to use the Medtronic Micra TPS because unlike traditional pacemakers, the device does not require cardiac wires (leads) or a surgical "pocket" under the skin to deliver a pacing therapy.
Instead, the device is small enough to be delivered through a catheter and implanted directly into the heart with small tines or prongs, providing a safe alternative to conventional pacemakers without the complications associated with leads -- all the while being cosmetically invisible.
The Micra TPS is also designed to automatically adjust pacing therapy based on a patient's activity levels.
"Latest innovation in pacemaker technology coupled with minimally invasive procedure increases the benefit to patient manifold. Not only is Micra TPS device MRI compatible, it also does not have wires like other traditional pacemakers which reduces the risks of infections caused due to wires," Singh said.
He added: "It's a keyhole procedure which makes it cosmetically viable and leaves no visible sign of a medical device under the skin."
--IANS
pradeep/ask/rn/vt
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
